Again, information and lower execution costs are where Insto's have an advantage over retail. In that former vein, just to let you know MACI got a feature in MSB's Bell Potter presentation when talking about its own degenerative disc disease treatment (I hate that they call it back pain - too unspecific). I believe the potential for chondrocytes in DDD well under-estimated, despite the known role of endplates degeneration (and tenocytes in the collagenous annulus fibrous):
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029037/
ACI has taken a back seat to CelGro and ATI - its only a small company with limited resources - but perhaps some future venture with Vericel not off the table. Orthocell actually compared themselves to Vericel quite a few years back:
- Forums
- ASX - By Stock
- Ann: Investor Presentation
Again, information and lower execution costs are where Insto's...
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.005(1.33%) |
Mkt cap ! $80.59M |
Open | High | Low | Value | Volume |
38.0¢ | 39.0¢ | 38.0¢ | $15.38K | 40.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 48060 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 23768 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.380 |
1 | 65604 | 0.375 |
2 | 56929 | 0.370 |
3 | 22650 | 0.365 |
6 | 46582 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 23768 | 2 |
0.390 | 29724 | 2 |
0.395 | 40540 | 1 |
0.400 | 65998 | 4 |
0.405 | 24000 | 2 |
Last trade - 14.27pm 13/05/2024 (20 minute delay) ? |
|
|||||
Last
38.0¢ |
  |
Change
0.005 ( 1.33 %) |
|||
Open | High | Low | Volume | ||
38.5¢ | 38.5¢ | 38.0¢ | 32068 | ||
Last updated 14.27pm 13/05/2024 ? |
Featured News
OCC (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online